Nearly 50 years after samples were officially collected from the Shroud of Turin, scientists have used advanced genetic ...

A fully automated process that promises to accelerate the preparation of bacterial samples for genetic sequencing has been ...

Next-generation sequencing refers to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding substantially more ...

Here are the latest biotech industry updates, including the program announcement for The Antibody Series 2026.

According to MarketsandMarkets™, the Multiomics Market is projected to reach USD 5.70 billion by 2031 from USD 3.18 billion in 2026, at a CAGR of 12.3% during the forecast period.

An international collaboration co-led by Harvard Medical School researchers at Dana-Farber Cancer Institute has created 665 ...

DNA traces in the Shroud of Turin reveal a remarkable mixture of human lineages, microbes, plants, animals, and coral accumulated through centuries of handling and travel. The findings do not prove ...

This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate ...

Fibers taken from the Shroud of Turin nearly five decades ago still contain a complex record of biological material ...

Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, ...

Key takeaways First large-scale, peer-reviewed research confirms HCMI model fidelity: A study published in Nature found that ...

A new review highlights how advances in DNA technology are reshaping the future of healthcare by shifting the focus from treatment to prevention ...